

Most Read This Week
- Isotretinoin Laboratory Monitoring in Acne Treatment
- Laboratory Testing for Pediatric Patients Undergoing Isotretinoin Treatment
- Intradermal Botulinum Toxin A Injection vs Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis
- Efficacy and Safety of Tofacitinib, Peficitinib, Solcitinib, Baricitinib, Abrocitinib, and Deucravacitinib in Plaque Psoriasis
- Routine Re-Screening for Latent TB Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics
Recently Updated
- Experts Address Lab Monitoring of Isotretinoin for Treating Acne
- Intradermal Botulinum Toxin A Injection vs Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis
- Disinfection Trials With Terbinafine-Susceptible and Terbinafine-Resistant Dermatophytes
- Secukinumab for the Treatment of Adult-Onset Pityriasis Rubra Pilaris
- Isotretinoin Laboratory Monitoring in Acne Treatment